These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 18180005

  • 21. Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury.
    Kalb RE, Helm TN, Sperry H, Thakral C, Abraham JL, Kanal E.
    Br J Dermatol; 2008 Mar; 158(3):607-10. PubMed ID: 18076707
    [Abstract] [Full Text] [Related]

  • 22. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.
    Kribben A, Witzke O, Hillen U, Barkhausen J, Daul AE, Erbel R.
    J Am Coll Cardiol; 2009 May 05; 53(18):1621-8. PubMed ID: 19406336
    [Abstract] [Full Text] [Related]

  • 23. Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness.
    Canavese C, Mereu MC, Aime S, Lazzarich E, Fenoglio R, Quaglia M, Stratta P.
    J Nephrol; 2008 May 05; 21(3):324-36. PubMed ID: 18587720
    [Abstract] [Full Text] [Related]

  • 24. [Nephrogenic systemic fibrosis and gadolinium-based contrast media].
    Andréjak M, Thuillier D, Lok C, Gras-Champel V.
    Therapie; 2007 May 05; 62(2):169-72. PubMed ID: 17582319
    [Abstract] [Full Text] [Related]

  • 25. Transglutaminases: the missing link in nephrogenic systemic fibrosis.
    Parsons AC, Yosipovitch G, Sheehan DJ, Sangüeza OP, Greenberg CS, Sane DC.
    Am J Dermatopathol; 2007 Oct 05; 29(5):433-6. PubMed ID: 17890909
    [Abstract] [Full Text] [Related]

  • 26. MRI contrast media are used to improve visualization of abnormal structures or lesions in various parts of the body. Introduction.
    Thomsen HS, Marckmann P.
    Eur J Radiol; 2008 May 05; 66(2):153-9. PubMed ID: 18343071
    [Abstract] [Full Text] [Related]

  • 27. Response to editorial: animal models for nephrogenic systemic fibrosis.
    Sieber MA, Lengsfeld P, Pietsch H.
    Acta Radiol; 2008 Oct 05; 49(8):963-4. PubMed ID: 18798020
    [No Abstract] [Full Text] [Related]

  • 28. Nephrogenic systemic fibrosis--the beginning of the end?
    Heymann WR.
    J Am Acad Dermatol; 2007 Jul 05; 57(1):171-2. PubMed ID: 17572281
    [No Abstract] [Full Text] [Related]

  • 29. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
    Broome DR.
    Eur J Radiol; 2008 May 05; 66(2):230-4. PubMed ID: 18372138
    [Abstract] [Full Text] [Related]

  • 30. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis.
    High WA, Ayers RA, Chandler J, Zito G, Cowper SE.
    J Am Acad Dermatol; 2007 Jan 05; 56(1):21-6. PubMed ID: 17097388
    [Abstract] [Full Text] [Related]

  • 31. [Nephrogenic systemic fibrosis].
    Cavallini L, Abaterusso C, Bedogna V, Pertica N, Loschiavo C, Lupo A.
    G Ital Nefrol; 2008 Jan 05; 25(1):14-20. PubMed ID: 18264914
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents--St. Louis, Missouri, 2002-2006.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2007 Feb 23; 56(7):137-41. PubMed ID: 17318112
    [Abstract] [Full Text] [Related]

  • 34. Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure--role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate.
    Yerram P, Saab G, Karuparthi PR, Hayden MR, Khanna R.
    Clin J Am Soc Nephrol; 2007 Mar 23; 2(2):258-63. PubMed ID: 17699422
    [Abstract] [Full Text] [Related]

  • 35. [Nephrogenic systemic fibrosis].
    Breitschaft A, Stahlmann R.
    Med Monatsschr Pharm; 2009 Oct 23; 32(10):377-82. PubMed ID: 19886227
    [Abstract] [Full Text] [Related]

  • 36. Nephrogenic systemic fibrosis--implications for nephrologists.
    Saab G, Abu-Alfa A.
    Eur J Radiol; 2008 May 23; 66(2):208-12. PubMed ID: 18342470
    [Abstract] [Full Text] [Related]

  • 37. Nephrogenic systemic fibrosis: a clinicopathologic study of six cases.
    Pryor JG, Poggioli G, Galaria N, Gust A, Robison J, Samie F, Hanjani NM, Scott GA.
    J Am Acad Dermatol; 2007 Jul 23; 57(1):105-11. PubMed ID: 17412451
    [Abstract] [Full Text] [Related]

  • 38. Nephrogenic systemic fibrosis, kidney disease, and gadolinium: is there a link?
    Perazella MA.
    Clin J Am Soc Nephrol; 2007 Mar 23; 2(2):200-2. PubMed ID: 17699407
    [No Abstract] [Full Text] [Related]

  • 39. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists.
    Prasad SR, Jagirdar J.
    J Comput Assist Tomogr; 2008 Mar 23; 32(1):1-3. PubMed ID: 18303280
    [Abstract] [Full Text] [Related]

  • 40. Nephrogenic systemic fibrosis: more questions and some answers.
    Morcos SK, Thomsen HS.
    Nephron Clin Pract; 2008 Mar 23; 110(1):c24-31; discussion c32. PubMed ID: 18688172
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.